Smartemis Scales a New Model for Growth

INVESTOR

A group of experienced investors who had seen too many failed roll-ups in the veterinary sector and were skeptical of yet another platform promising better execution. 

CHALLENGE 

At the outset, Smartemis had no clinics, no revenue, and no direct precedent in animal health. The concept was radically different: a capital-light, partnership-based model designed to preserve autonomy by focusing on alignment of interest rather than control. To early investors, it looked like a moonshot—untested, hard to benchmark, and easy to dismiss. 

TURNING POINT 

Rather than selling a vision through hype, Smartemis built conviction through discipline. The team validated unmet market needs, selected test markets with precision and mapped a financial engine that balanced growth with capital efficiency. A seasoned leadership team, with deep healthcare and investor-backed experience, anchored credibility. The December 2020 model became the anchor for belief. 

TRANSFORMATION 

Initial skepticism gave way to traction. The company's seed financing, completed in 2021, projected 110 clinics and 137M € in clinic revenue by the end of 2025. Smartemis significantly exceeded those already aggressive targets, achieving 131 clinics with 157M € in revenue. In addition to rapid network growth, clinic organic growth rates have significantly exceeded market averages. The model didn't just work; it scaled faster and more efficiently than expected.

LOOKING AHEAD 

Smartemis now stands as a proven alternative to traditional consolidation: a capital-efficient, alignment-driven platform that compounds value through partnership, not control. With trust established, performance validated and a growing pipeline across Europe, Smartemis is poised to deepen its impact and expand its network sustainably. 

For investors, this is more than upside potential—it’s downside protection through aligned incentives, disciplined execution, and a model built to endure.